Exo rakes in $220m Series C

Exo, a health information and devices company, has secured $220 million in Series C funding.

Exo, a health information and devices company, has secured $220 million in Series C funding. RA Capital Management led the round with participation from BlackRock, Sands Capital, Avidity Partners and Pura Vida Investments.

Source: Press Release